Fingerprint
Dive into the research topics of 'Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
Na Luo, Luigi Formisano, Paula I. Gonzalez-Ericsson, Violeta Sanchez, Phillip T. Dean, Susan R. Opalenik, Melinda E. Sanders, Rebecca S. Cook, Carlos L. Arteaga, Douglas B. Johnson, Justin M. Balko
Research output: Contribution to journal › Article › peer-review
54
Scopus
citations